Showing results (141-150 of 148) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|January 1, 1982
New hormonal therapy in prostatic carcinoma: combined treatment with an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.The Prostate|November 14, 2000
Induction of apoptosis and inhibition of cell proliferation by the lipido-sterolic extract of Serenoa repens (LSESr, Permixon in benign prostatic hyperplasiaF Vacherot, M Azzouz, S Gil-Diez-De-Medina, et al.Journal of Steroid Biochemistry|July 1, 1983
New hormonal treatment in cancer of the prostate: combined administration of an LHRH agonist and an antiandrogenF Labrie, A Dupont, A Belanger, et al.Bulletin De La Societe De Pathologie Exotique (1990)|June 22, 2019
[HIV Disclosure to the Child/Adolescent in Central and West Francophone Africa]D L Dahourou, D Masson, H Aka-Dago-Akribi, et al.American Journal of Physiology. Endocrinology and Metabolism|December 20, 2000
Effects of hyperprolactinemia on rat prostate growth: evidence of androgeno-dependenceF Van Coppenolle, C Slomianny, F Carpentier, et al.L'Encephale|January 11, 2022
Predictive factors for the outcome of emotional and/or behavioural disorders in 18- to 48-month-old children after parent-child psychotherapy: Protocol of a European prospective cohort studyM-J Hervé, V Maurice, L Gamon, et al.Psychotherapy Research : Journal of the Society for Psychotherapy Research|August 5, 2024
Psychometric properties of the French Infant-Toddler Working Alliance Inventory Short version (IT-WAI-S)M-J Hervé, A Visier, S Aouinti, et al.The Prostate|October 1, 1996
Comparison of phytotherapy (Permixon) with finasteride in the treatment of benign prostate hyperplasia: a randomized international study of 1,098 patientsJ C Carraro, J P Raynaud, G Koch, et al.Pageof 15